Screener
Iovance Biotherapeutics, Inc. IOVA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ Equity | ||
| Series A Convertible Preferred stock, $0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Series B Convertible Preferred stock, $0.001 par value; 11,500,000 shares designated, 1,932,667 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | 2 | 2 |
| Common stock, $0.000041666 par value; 650,000,000 shares authorized, 452,971,016 and 411,938,061 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 19 | 17 |
| Accumulated other comprehensive income | 13,078 | 16,440 |
| Additional paid-in capital | 3,624,836 | 3,457,654 |
| Accumulated deficit | (2,901,890) | (2,775,530) |
| Total Stockholders’ Equity | 736,045 | 698,583 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s common stock?
- Iovance Biotherapeutics, Inc. (IOVA) reported common stock of $19K in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s common stock changed year-over-year?
- Iovance Biotherapeutics, Inc.'s common stock increased by 35.7% year-over-year, from $14K to $19K.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s common stock has grown at a 23.2% compound annual growth rate (CAGR), from $6K to $17K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Iovance Biotherapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude